Literature DB >> 15793111

Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient.

Aurélie Thiolas1, Claude Bollet, Bernard La Scola, Didier Raoult, Jean-Marie Pagès.   

Abstract

Enterobacter aerogenes is an agent of hospital-acquired infection that exhibits a remarkable resistance to beta-lactam antibiotics during therapy. Five successive isolates of E. aerogenes infecting a patient and exhibiting a multiresistance phenotype to beta-lactam antibiotics and fluoroquinolones were investigated. Among these clinical strains, four presented resistant phenotypes during successive imipenem and colistin treatments. The involved resistance mechanisms exhibited by the successive isolates were associated with alterations of the outer membrane that caused a porin decrease and lipopolysaccharide modifications.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15793111      PMCID： PMC1068582          DOI： 10.1128/AAC.49.4.1354-1358.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  35 in total

1.  Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains.

Authors:  Monique Malléa; Jacqueline Chevalier; Annie Eyraud; Jean-Marie Pagès
Journal:  Biochem Biophys Res Commun       Date:  2002-05-24       Impact factor: 3.575

2.  National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998.

Authors:  Y De Gheldre; M J Struelens; Y Glupczynski; P De Mol; N Maes; C Nonhoff; H Chetoui; C Sion; O Ronveaux; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA.

Authors:  T M Barbosa; S B Levy
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

4.  Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997.

Authors:  D J Diekema; M A Pfaller; R N Jones; G V Doern; P L Winokur; A C Gales; H S Sader; K Kugler; M Beach
Journal:  Clin Infect Dis       Date:  1999-09       Impact factor: 9.079

5.  Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital.

Authors:  H Mammeri; G Laurans; M Eveillard; S Castelain; F Eb
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

6.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.

Authors:  E H Ibrahim; G Sherman; S Ward; V J Fraser; M H Kollef
Journal:  Chest       Date:  2000-07       Impact factor: 9.410

7.  Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period.

Authors:  Rafael Cantón; Antonio Oliver; Teresa M Coque; María del Carmen Varela; José Claudio Pérez-Díaz; Fernando Baquero
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

8.  Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.

Authors:  O Lomovskaya; M S Warren; A Lee; J Galazzo; R Fronko; M Lee; J Blais; D Cho; S Chamberland; T Renau; R Leger; S Hecker; W Watkins; K Hoshino; H Ishida; V J Lee
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

9.  Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability.

Authors:  C Bornet; A Davin-Regli; C Bosi; J M Pages; C Bollet
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

10.  Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.

Authors:  J W Chow; M J Fine; D M Shlaes; J P Quinn; D C Hooper; M P Johnson; R Ramphal; M M Wagener; D K Miyashiro; V L Yu
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391
View more
  24 in total

1.  An early response to environmental stress involves regulation of OmpX and OmpF, two enterobacterial outer membrane pore-forming proteins.

Authors:  Myrielle Dupont; Chloë E James; Jacqueline Chevalier; Jean-Marie Pagès
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

2.  Genetic analysis of colistin resistance in Salmonella enterica serovar Typhimurium.

Authors:  Song Sun; Aurel Negrea; Mikael Rhen; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

3.  Polymyxin-resistant clinical isolates of Escherichia coli.

Authors:  Carl Urban; Hemavarna Tiruvury; Noriel Mariano; Rita Colon-Urban; James J Rahal
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

4.  Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.

Authors:  Sheila Adams-Sapper; Shantell Nolen; Grace Fox Donzelli; Mallika Lal; Kunihiko Chen; Livia Helena Justo da Silva; Beatriz M Moreira; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

5.  Whole-genome sequence of Chryseobacterium oranimense, a colistin-resistant bacterium isolated from a cystic fibrosis patient in France.

Authors:  Poonam Sharma; Sushim Kumar Gupta; Seydina M Diene; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

Review 6.  Porins and small-molecule translocation across the outer membrane of Gram-negative bacteria.

Authors:  Julia Vergalli; Igor V Bodrenko; Muriel Masi; Lucile Moynié; Silvia Acosta-Gutiérrez; James H Naismith; Anne Davin-Regli; Matteo Ceccarelli; Bert van den Berg; Mathias Winterhalter; Jean-Marie Pagès
Journal:  Nat Rev Microbiol       Date:  2019-12-02       Impact factor: 60.633

Review 7.  Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

8.  Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria.

Authors:  Marcela Nastro; Carlos Hernan Rodríguez; Renata Monge; Jonathan Zintgraff; Liliana Neira; Mirta Rebollo; Carlos Vay; Angela Famiglietti
Journal:  J Chemother       Date:  2013-12-06       Impact factor: 1.714

Review 9.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  Carbapenem- and Colistin-Resistant Enterobacter cloacae from Delta, Colorado, in 2015.

Authors:  Andrew P Norgan; Jarred M Freese; Patricia M Tuin; Scott A Cunningham; Patricio R Jeraldo; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.